Previous 10 | Next 10 |
Illumina scientists tailor-made research solutions for detecting genes in difficult-to-read regions that cause both common and rare diseases Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / March 8, 2024 / When scientists want to sequence a DNA sample on an Il...
NORTHAMPTON, MA / ACCESSWIRE / March 7, 2024 / Illumina WorldFish and the Earlham Institute are using genomics to improve tilapia for the sake of global food sustainability Originally published on Illumina News Center The United Nations projects that the total human population will ex...
2024-02-28 04:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-26 18:29:00 ET Gene-sequencing stock Illumina (NASDAQ: ILMN) was a standout in the biotech sector Monday, with its share-price rise convincingly beating the S&P 500 index. Investors were cheered by a stock buy made by a high-profile insider. As a result, its shares c...
2024-02-23 04:50:00 ET Summary Polen Capital is a high-conviction growth investment manager. We scour the globe in search of the highest quality, sustainable companies to invest in. The Polen Focus Growth Composite Portfolio (the “Portfolio”) outpaced the Russell 100...
2024-02-23 03:42:37 ET Summary Illumina's stock declined 19% post "Sell" recommendation; S&P 500 rose 10%, highlighting concerns over GRAIL acquisition legal risks. 2023 revenue fell to $4,504 million from $4,584 million, with gross margins dropping from 69.6% in 2021 to 60.9%...
2024-02-18 03:45:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Fifth Avenue Growth Fund® (the Fund) was up 17.6% (Institutional Shares) in...
2024-02-18 03:05:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. During Q4 2023, Baron Opportunity Fund rose 15.10% (inst.) and for the full-year 2023,...
2024-02-17 10:15:00 ET Summary Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing. Baron Focused Growth Fund increased 9.74% (inst. shares) in Q4 2023 underperforming th...
2024-02-17 05:05:44 ET In 2023, revenue decreased by 2% due to lower sales in sequencing consumables and instruments. Operating expenses showed significant changes, impacting net income margin. Management focuses on strategic collaborations and cash management. Key performance indicators rema...
News, Short Squeeze, Breakout and More Instantly...
Illumina to Present Upcoming Strategy Update PR Newswire SAN DIEGO , July 18, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ: ILMN) previously announced on June 24 , the company will present a Strategy Update on Tuesday, August 13, 2024 starting at ...
Illumina to Announce Second Quarter 2024 Financial Results on Tuesday, August 6, 2024 PR Newswire SAN DIEGO , July 11, 2024 /PRNewswire/ -- As Illumina, Inc. (NASDAQ:ILMN) previously announced on June 24 , the company will issue results for the second qu...
The Illumina iHope China program will provide 1800 families with genetic testing in 2024, broadening its reach and impact nationwide Originally published on Illumina News Center NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / This year may be the most impactful yet in the short history o...